In an April 15 Executive Order, entitled “Lowering Drug Prices by Once Again Putting Americans First,” the Trump Administration has called attention to an ERISA disclosure required by the Consolidated Appropriations Act of...more
4/18/2025
/ Benefit Plan Sponsors ,
Consolidated Appropriations Act (CAA) ,
Department of Labor (DOL) ,
Disclosure Requirements ,
Drug Pricing ,
Employer Group Health Plans ,
Executive Orders ,
Fee Disclosure ,
Financial Services Industry ,
Health Insurance ,
Pharmacy Benefit Manager (PBM) ,
Trump Administration
A February 19 Executive Order, titled “Ensuring Lawful Governance and Implementing the President’s ‘Department of Government Efficiency’ Deregulatory Initiative,” is aimed at directing the “Administration to focus the...more
Under recently finalized federal regulations (commonly referred to as the “Fiduciary Rule”) that were scheduled to become effective on September 23, 2024, the U.S. Department of Labor intended to expand the fiduciary...more
8/7/2024
/ 401k ,
Administrative Procedure Act ,
Chevron Deference ,
Department of Labor (DOL) ,
Employee Benefits ,
Employee Retirement Income Security Act (ERISA) ,
Fiduciary ,
Fiduciary Rule ,
Individual Retirement Account (IRA) ,
Investment Adviser ,
Loper Bright Enterprises v Raimondo ,
Prohibited Transactions ,
Retirement Plan ,
Stays